AVBP ARRIVENT BIOPHARMA
Health Care · Russell 2000
Next earnings: Mon 16 Nov 2026 · estimated
What 14 analyst firms say about ARRIVENT BIOPHARMA: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 16 analyst/firm records · 14 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #59 in the index84
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8067
Recent analyst activity · last 90 days
Our tracked history has 23 reports on AVBP from 12 analyst firms in the last 90 days (14 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target, 3 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Guggenheim raised its target from $18.00 (set 7 Oct 2026) to $30.00 on 27 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Kalpit Patel | Buy | 20 Oct 2026 | 29.00 USD |
| B Riley Securities | Mayank Mamtani | Buy | 13 Aug 2026 | 29.00 USD |
| BTIG | Jeet Mukherjee | Buy | 16 Oct 2026 | 29.00 USD |
| Cantor Fitzgerald | Li Watsek | Buy | 22 Sep 2026 | — |
| Citigroup | Yigal Nochomovitz | Buy | 7 Oct 2026 | 20.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 6 Oct 2026 | 22.00 USD |
| Guggenheim | Michael Schmidt | Buy | 27 Oct 2026 | 30.00 USD |
| Guggenheim | Michael Schmitz | Buy | 7 Oct 2026 | 18.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 8 Oct 2026 | 27.00 USD |
| Jefferies | Roger Song | Buy | 7 Oct 2026 | 27.00 USD |
| Jonestrading | Soumit Roy | Buy | 7 Oct 2026 | 22.00 USD |
| Lifesci Capital | Sam Slutsky | Buy | 6 Mar 2026 | 42.00 USD |
| Oppenheimer | Jeff Jones | Buy | 6 Mar 2026 | 50.00 USD |
| Truist | Supawat Thongthip | — | 26 Oct 2026 | 21.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.